ANIK logo

Anika Therapeutics (ANIK) Shareholders Equity

Annual Shareholders Equity

$212.26 M
-$73.30 M-25.67%

31 December 2023

ANIK Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Shareholders Equity

$179.86 M
-$30.47 M-14.49%

30 September 2024

ANIK Quarterly Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ANIK Shareholders Equity Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-25.7%-33.5%
3 y3 years-22.1%-38.0%
5 y5 years-19.5%-36.1%

ANIK Shareholders Equity High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-26.1%at low-38.0%at low
5 y5 years-26.4%at low-38.8%at low
alltimeall time-26.4%+4145.3%-38.8%+3897.0%

Anika Therapeutics Shareholders Equity History

DateAnnualQuarterly
Sept 2024
-
$179.86 M(-14.5%)
June 2024
-
$210.34 M(+0.9%)
Mar 2024
-
$208.54 M(-1.8%)
Dec 2023
$212.26 M(-25.7%)
$212.26 M(-21.5%)
Sept 2023
-
$270.49 M(-1.3%)
June 2023
-
$274.01 M(-1.3%)
Mar 2023
-
$277.59 M(-2.8%)
Dec 2022
$285.56 M(-0.5%)
$285.56 M(+0.2%)
Sept 2022
-
$284.94 M(-0.4%)
June 2022
-
$286.15 M(+0.1%)
Mar 2022
-
$285.79 M(-0.5%)
Dec 2021
$287.08 M(+5.4%)
$287.08 M(-1.0%)
Sept 2021
-
$290.06 M(+1.1%)
June 2021
-
$286.80 M(+3.7%)
Mar 2021
-
$276.66 M(+1.6%)
Dec 2020
$272.40 M(-5.5%)
$272.40 M(-4.2%)
Sept 2020
-
$284.45 M(-1.4%)
June 2020
-
$288.44 M(-1.8%)
Mar 2020
-
$293.69 M(+1.8%)
Dec 2019
$288.38 M(+9.4%)
$288.38 M(+2.4%)
Sept 2019
-
$281.68 M(+12.2%)
June 2019
-
$250.95 M(-6.7%)
Mar 2019
-
$269.07 M(+2.1%)
Dec 2018
$263.61 M(+0.0%)
$263.61 M(+3.3%)
Sept 2018
-
$255.26 M(+3.5%)
June 2018
-
$246.60 M(-6.5%)
Mar 2018
-
$263.77 M(+0.1%)
Dec 2017
$263.49 M(+18.3%)
$263.49 M(+4.0%)
Sept 2017
-
$253.29 M(+3.7%)
June 2017
-
$244.14 M(+6.1%)
Mar 2017
-
$230.03 M(+3.3%)
Dec 2016
$222.77 M(+5.7%)
$222.77 M(+3.8%)
Sept 2016
-
$214.54 M(+5.0%)
June 2016
-
$204.42 M(+4.6%)
Mar 2016
-
$195.37 M(-7.3%)
Dec 2015
$210.85 M(+18.4%)
$210.85 M(+5.6%)
Sept 2015
-
$199.75 M(+4.8%)
June 2015
-
$190.57 M(+4.8%)
Mar 2015
-
$181.82 M(+2.1%)
Dec 2014
$178.10 M(+31.3%)
$178.10 M(+4.9%)
Sept 2014
-
$169.70 M(+4.5%)
June 2014
-
$162.39 M(+3.7%)
Mar 2014
-
$156.57 M(+15.4%)
Dec 2013
$135.63 M(+24.5%)
$135.63 M(+5.8%)
Sept 2013
-
$128.21 M(+7.3%)
June 2013
-
$119.43 M(+5.9%)
Mar 2013
-
$112.83 M(+3.6%)
Dec 2012
$108.93 M(+14.9%)
$108.93 M(+5.3%)
Sept 2012
-
$103.47 M(+2.7%)
June 2012
-
$100.75 M(+2.5%)
Mar 2012
-
$98.26 M(+3.7%)
Dec 2011
$94.76 M(+11.2%)
$94.76 M(+2.1%)
Sept 2011
-
$92.85 M(+1.9%)
June 2011
-
$91.13 M(+4.0%)
Mar 2011
-
$87.61 M(+2.8%)
Dec 2010
$85.19 M(+3.7%)
$85.19 M(+1.0%)
Sept 2010
-
$84.38 M(+5.7%)
June 2010
-
$79.82 M(-1.8%)
Mar 2010
-
$81.28 M(-1.0%)
Dec 2009
$82.14 M(+35.2%)
$82.14 M(+27.7%)
Sept 2009
-
$64.33 M(+2.9%)
June 2009
-
$62.54 M(+2.0%)
Mar 2009
-
$61.33 M(+0.9%)
Dec 2008
$60.76 M
$60.76 M(+2.5%)
DateAnnualQuarterly
Sept 2008
-
$59.27 M(+2.5%)
June 2008
-
$57.80 M(+2.3%)
Mar 2008
-
$56.48 M(+2.8%)
Dec 2007
$54.96 M(+20.8%)
$54.96 M(+4.4%)
Sept 2007
-
$52.62 M(+4.5%)
June 2007
-
$50.34 M(+5.9%)
Mar 2007
-
$47.55 M(+4.5%)
Dec 2006
$45.49 M(+20.0%)
$45.49 M(+3.5%)
Sept 2006
-
$43.94 M(+5.5%)
June 2006
-
$41.65 M(+4.9%)
Mar 2006
-
$39.71 M(+4.8%)
Dec 2005
$37.89 M(+24.8%)
$37.89 M(+2.2%)
Sept 2005
-
$37.06 M(+7.4%)
June 2005
-
$34.51 M(+8.4%)
Mar 2005
-
$31.84 M(+4.9%)
Dec 2004
$30.36 M(+68.8%)
$30.36 M(+8.9%)
Sept 2004
-
$27.89 M(+3.9%)
June 2004
-
$26.83 M(+4.1%)
Mar 2004
-
$25.78 M(+43.3%)
Dec 2003
$17.98 M(+5.4%)
$17.98 M(+4.8%)
Sept 2003
-
$17.15 M(+2.8%)
June 2003
-
$16.68 M(-0.4%)
Mar 2003
-
$16.75 M(-1.8%)
Dec 2002
$17.06 M(-15.1%)
$17.06 M(+4.0%)
Sept 2002
-
$16.40 M(-4.3%)
June 2002
-
$17.14 M(-6.3%)
Mar 2002
-
$18.30 M(-9.0%)
Dec 2001
$20.10 M(-24.7%)
$20.10 M(-2.2%)
Sept 2001
-
$20.56 M(-6.0%)
June 2001
-
$21.87 M(-10.6%)
Mar 2001
-
$24.47 M(-8.4%)
Dec 2000
$26.71 M(+3.9%)
$26.71 M(+9.9%)
Sept 2000
-
$24.30 M(-5.1%)
June 2000
-
$25.62 M(+1.2%)
Mar 2000
-
$25.32 M(-1.5%)
Dec 1999
$25.70 M(-14.0%)
$25.70 M(-12.9%)
Sept 1999
-
$29.50 M(+0.3%)
June 1999
-
$29.40 M(+3.5%)
Mar 1999
-
$28.40 M(-5.0%)
Dec 1998
$29.90 M(+14.1%)
$29.90 M(-2.9%)
Sept 1998
-
$30.80 M(+2.7%)
June 1998
-
$30.00 M(+8.7%)
Mar 1998
-
$27.60 M(+5.3%)
Dec 1997
$26.20 M(+424.0%)
$26.20 M(+344.1%)
Sept 1997
-
$5.90 M(0.0%)
June 1997
-
$5.90 M(+7.3%)
Mar 1997
-
$5.50 M(-12.7%)
Dec 1996
$5.00 M(-27.5%)
-
Nov 1996
-
$6.30 M(-8.7%)
Aug 1996
-
$6.90 M(-10.4%)
Aug 1996
$6.90 M(+19.0%)
-
May 1996
-
$7.70 M(+71.1%)
Feb 1996
-
$4.50 M(-16.7%)
Nov 1995
-
$5.40 M(-6.9%)
Aug 1995
$5.80 M(+7.4%)
$5.80 M(-12.1%)
May 1995
-
$6.60 M(+37.5%)
Feb 1995
-
$4.80 M(-4.0%)
Nov 1994
-
$5.00 M(-7.4%)
Aug 1994
$5.40 M(-19.4%)
$5.40 M(-8.5%)
May 1994
-
$5.90 M(-7.8%)
Feb 1994
-
$6.40 M(-3.0%)
Nov 1993
-
$6.60 M(-1.5%)
Aug 1993
$6.70 M
$6.70 M(-8.2%)
May 1993
-
$7.30 M

FAQ

  • What is Anika Therapeutics annual stockholders equity?
  • What is the all time high annual shareholders equity for Anika Therapeutics?
  • What is Anika Therapeutics annual shareholders equity year-on-year change?
  • What is Anika Therapeutics quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Anika Therapeutics?
  • What is Anika Therapeutics quarterly shareholders equity year-on-year change?

What is Anika Therapeutics annual stockholders equity?

The current annual shareholders equity of ANIK is $212.26 M

What is the all time high annual shareholders equity for Anika Therapeutics?

Anika Therapeutics all-time high annual stockholders equity is $288.38 M

What is Anika Therapeutics annual shareholders equity year-on-year change?

Over the past year, ANIK annual stockholders equity has changed by -$73.30 M (-25.67%)

What is Anika Therapeutics quarterly stockholders equity?

The current quarterly shareholders equity of ANIK is $179.86 M

What is the all time high quarterly shareholders equity for Anika Therapeutics?

Anika Therapeutics all-time high quarterly stockholders equity is $293.69 M

What is Anika Therapeutics quarterly shareholders equity year-on-year change?

Over the past year, ANIK quarterly stockholders equity has changed by -$90.62 M (-33.50%)